About CTI Science
CTI Science is a company based in Lexington (United States) founded in 2007 was acquired by EmeraMed in July 2014. CTI Science has raised $3.97 million across 2 funding rounds from investors including EmeraMed. CTI Science offers products and services including Emeramide and Early Access Program.
- Headquarter Lexington, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Emeramed Ltd
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of CTI Science
CTI Science offers a comprehensive portfolio of products and services, including Emeramide and Early Access Program.
A drug that chelates heavy metals and reduces oxidative stress in the body.
Program providing access to Emeramide for patients before full approval.
Funding Insights of CTI Science
CTI Science has successfully raised a total of $3.97M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $271 thousand completed in January 2014. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in CTI Science
CTI Science has secured backing from 1 investor. Prominent investors backing the company include EmeraMed.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Therapeutics for mercury toxicity treatment are developed by EmeraMed.
|
Locked | Locked | Locked |
Investor details for CTI Science
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by CTI Science
Investment portfolio details for CTI Science
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - CTI Science
Detailed financials for CTI Science
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Cti Science Comparisons
Peer comparison for CTI Science
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of CTI Science
Detailed competitors of CTI Science
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Cti Science
Complete news archive for CTI Science
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about CTI Science
CTI Science was founded in 2007 and raised its 1st funding round 6 years after it was founded.
CTI Science is headquartered in Lexington, United States. It is registered at Lexington, Kentucky, United States.
CTI Science is a funded company, having raised a total of $3.97M across 2 funding rounds to date.
CTI Science, formerly known as Chelator Technologies produces dietary antioxidants that maintain healthy glutathione levels in the body. They developed OSR1 which is an antioxidant product that scavenges free radicals and helps maintain healthy glutathione levels. Pharmacies halted the sales of this product six weeks after the U.S. Food and Drug Administration called the product an unapproved new drug.The company was later acquired by ERMES Medical in July 2014.
CTI Science offers Emeramide and Early Access Program.
CTI Science has 1 investor. Key investors include EmeraMed.